TRIPS Agreement (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "TRIPS Agreement" in English language version.

refsWebsite

Global rank English rank

34web.archive.org

1^st place

16wto.org

3,346^th place

3,227^th place

11doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3ulaval.ca

2,701^st place

5,106^th place

3worldtradelaw.net

low place

2cato.org

4,789^th place

3,253^rd place

1danielearchibugi.org

low place

1cambridge.org

305^th place

264^th place

1archive.today

14^th place

1ipjustice.org

low place

1jstor.org

26^th place

20^th place

1who.int

195^th place

302^nd place

1academia.edu

121^st place

142^nd place

1wiley.com

222^nd place

297^th place

1cigionline.org

low place

1oxfordscholarship.com

8,382^nd place

5,224^th place

1wto.int

low place

1upenn.edu

702^nd place

520^th place

1handle.net

102^nd place

76^th place

1nih.gov

4^th place

1wur.nl

8,218^th place

8,579^th place

1fordham.edu

1,648^th place

1,137^th place

1reuters.com

49^th place

47^th place

1theconversation.com

928^th place

651^st place

1amnesty.org

1,367^th place

1,176^th place

1aljazeera.com

268^th place

215^th place

1covid19response.org

low place

1devex.com

low place

academia.edu

J.-F. Morin; M. Bourassa. "Pharmaceutical patent policy in developing countries: learning from the Canadian experience". Intellectual Property, Pharmaceuticals and Public Health.

aljazeera.com

Pietromarchi, Virginia (1 March 2021). "Patently unfair: Can waivers help solve COVID vaccine inequality?". Al Jazeera. Retrieved 26 April 2021.

amnesty.org

"G7 leaders are shooting themselves in the foot by failing to tackle global vaccine access". Amnesty International. 19 February 2021. Retrieved 25 April 2021.

archive.today

IP Justice policy paper for the WIPO development agenda, IP Justice, archived from the original on 8 January 2013

cambridge.org

Sell, Susan K. (2003). Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge University Press. doi:10.1017/cbo9780511491665. ISBN 978-0-521-81914-5.

cato.org

Finger, J. Michael (2000). "The WTO's special burden on less developed countries" (PDF). Cato Journal. 19 (3). Archived from the original (PDF) on 28 July 2006.
"An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines". Cato Institute. 16 December 2020. Archived from the original on 25 February 2021. Retrieved 25 February 2021.

cigionline.org

Jean-Frederic Morin and Dimitri Theriault, How Trade Deals Extend the Frontiers of International Patent Law Archived 6 December 2018 at the Wayback Machine, CIGI Paper 199, 2018; Overview of "TRIPS-Plus" Standards – Oxford Scholarship. Oxford University Press. 2011. doi:10.1093/acprof:oso/9780195390124.003.0009. ISBN 978-0-19-989453-6. Archived from the original on 4 July 2014. Retrieved 7 October 2013.

covid19response.org

"TRIPS Waiver | Covid-19 Response". covid19response.org.

danielearchibugi.org

Archibugi, D.; Filippetti, A. (2010). "The globalization of intellectual property rights: Four learned lessons and four thesis" (PDF). Journal of Global Policy. 1 (2): 137–149. doi:10.1111/j.1758-5899.2010.00019.x. Archived from the original (PDF) on 25 July 2011.

devex.com

"WTO finally agrees on a TRIPS deal. But not everyone is happy". Devex. 17 June 2022.

doi.org

Archibugi, D.; Filippetti, A. (2010). "The globalization of intellectual property rights: Four learned lessons and four thesis" (PDF). Journal of Global Policy. 1 (2): 137–149. doi:10.1111/j.1758-5899.2010.00019.x. Archived from the original (PDF) on 25 July 2011.
Sell, Susan K. (2003). Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge University Press. doi:10.1017/cbo9780511491665. ISBN 978-0-521-81914-5.
J.-F. Morin; R. Gold (2014). "An Integrated Model of Legal Transplantation: The Diffusion of Intellectual Property Law in Developing Countries" (PDF). International Studies Quarterly. 58 (4): 781–792. doi:10.1111/isqu.12176. Archived (PDF) from the original on 28 September 2018. Retrieved 24 July 2017.
Banerjee, Tannista; Nayak, Arnab (14 March 2014). "Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry". Journal of Pharmaceutical Health Services Research. 5 (2): 89–94. doi:10.1111/jphs.12050. S2CID 70896207.
Jean-Frederic Morin and Dimitri Theriault, How Trade Deals Extend the Frontiers of International Patent Law Archived 6 December 2018 at the Wayback Machine, CIGI Paper 199, 2018; Overview of "TRIPS-Plus" Standards – Oxford Scholarship. Oxford University Press. 2011. doi:10.1093/acprof:oso/9780195390124.003.0009. ISBN 978-0-19-989453-6. Archived from the original on 4 July 2014. Retrieved 7 October 2013.
Xiong, Ping (2012b). "Patents in TRIPS-Plus Provisions and the Approaches to Interpretation of Free Trade Agreements and TRIPS: Do They Affect Public Health?". Journal of World Trade. 46 (1): 155. doi:10.54648/TRAD2012006.
Troullier, Patrice; et al. (22 June 2002). "Drug development for neglected diseases: a deficient market and a public-health policy failure". The Lancet. 359 (9324): 2188–2194. doi:10.1016/S0140-6736(02)09096-7. hdl:10144/28441. PMID 12090998. S2CID 1616485.
Baten, Jörg; Bianchi, Nicola; Moser, Petra (2017). "Compulsory licensing and innovation–Historical evidence from German patents after WWI". Journal of Development Economics. 126: 231–242. doi:10.1016/j.jdeveco.2017.01.002.
Morin, Jean-Frederic (2006). "Tripping up TRIPs Debate: IP and Health" (PDF). International Journal of Intellectual Property Management. 1 (1/2): 37–53. doi:10.1504/IJIPM.2006.011021. Archived from the original (PDF) on 1 December 2017.
Timmermann, Cristian; Henk van den Belt (2013). "Intellectual property and global health: from corporate social responsibility to the access to knowledge movement". Liverpool Law Review. 34 (1): 47–73. doi:10.1007/s10991-013-9129-9. S2CID 145492036. Archived from the original on 23 June 2020. Retrieved 31 October 2020.
Morin, Jean-Frederic (2011). "The Life-Cycle of Transnational Issues: Lessons from the Access to Medicines Controversy" (PDF). Global Society. 25 (2): 227–247. doi:10.1080/13600826.2011.553914. S2CID 216592972. Archived from the original (PDF) on 6 December 2018 – via Chaire de recherche du Canada en économie politique internationale.

fordham.edu

ir.lawnet.fordham.edu

Tosato, Andrea; Igbokwe, Ezinne (January 2023). "Access to Medicines and Pharmaceutical Patents: Fulfilling the Promise of TRIPS Article 31bis". Fordham Law Review. 91 (5): 1791. Archived from the original on 17 December 2023. Retrieved 23 July 2023.

handle.net

hdl.handle.net

Troullier, Patrice; et al. (22 June 2002). "Drug development for neglected diseases: a deficient market and a public-health policy failure". The Lancet. 359 (9324): 2188–2194. doi:10.1016/S0140-6736(02)09096-7. hdl:10144/28441. PMID 12090998. S2CID 1616485.

ipjustice.org

IP Justice policy paper for the WIPO development agenda, IP Justice, archived from the original on 8 January 2013

jstor.org

Blouin, Chantal; Heymann, Jody; Drager, Nick (2007). Trade and Health. McGill-Queen's University Press. p. 33. ISBN 9780773532816. JSTOR j.ctt812g5.

nih.gov

pubmed.ncbi.nlm.nih.gov

Troullier, Patrice; et al. (22 June 2002). "Drug development for neglected diseases: a deficient market and a public-health policy failure". The Lancet. 359 (9324): 2188–2194. doi:10.1016/S0140-6736(02)09096-7. hdl:10144/28441. PMID 12090998. S2CID 1616485.

oxfordscholarship.com

Jean-Frederic Morin and Dimitri Theriault, How Trade Deals Extend the Frontiers of International Patent Law Archived 6 December 2018 at the Wayback Machine, CIGI Paper 199, 2018; Overview of "TRIPS-Plus" Standards – Oxford Scholarship. Oxford University Press. 2011. doi:10.1093/acprof:oso/9780195390124.003.0009. ISBN 978-0-19-989453-6. Archived from the original on 4 July 2014. Retrieved 7 October 2013.

reuters.com

Nebehay, Stephanie; Farge, Emma (10 December 2020). "WTO delays decision on waiver on COVID-19 drug, vaccine rights". Reuters. Archived from the original on 28 February 2021. Retrieved 25 February 2021.

semanticscholar.org

api.semanticscholar.org

Banerjee, Tannista; Nayak, Arnab (14 March 2014). "Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry". Journal of Pharmaceutical Health Services Research. 5 (2): 89–94. doi:10.1111/jphs.12050. S2CID 70896207.
Troullier, Patrice; et al. (22 June 2002). "Drug development for neglected diseases: a deficient market and a public-health policy failure". The Lancet. 359 (9324): 2188–2194. doi:10.1016/S0140-6736(02)09096-7. hdl:10144/28441. PMID 12090998. S2CID 1616485.
Timmermann, Cristian; Henk van den Belt (2013). "Intellectual property and global health: from corporate social responsibility to the access to knowledge movement". Liverpool Law Review. 34 (1): 47–73. doi:10.1007/s10991-013-9129-9. S2CID 145492036. Archived from the original on 23 June 2020. Retrieved 31 October 2020.
Morin, Jean-Frederic (2011). "The Life-Cycle of Transnational Issues: Lessons from the Access to Medicines Controversy" (PDF). Global Society. 25 (2): 227–247. doi:10.1080/13600826.2011.553914. S2CID 216592972. Archived from the original (PDF) on 6 December 2018 – via Chaire de recherche du Canada en économie politique internationale.

theconversation.com

Baker, Brook K.; Labonte, Ronald (9 January 2021). "Dummy's guide to how trade rules affect access to COVID-19 vaccines". The Conversation. Archived from the original on 23 February 2021. Retrieved 25 February 2021.

ulaval.ca

chaire-epi.ulaval.ca

J.-F. Morin; R. Gold (2014). "An Integrated Model of Legal Transplantation: The Diffusion of Intellectual Property Law in Developing Countries" (PDF). International Studies Quarterly. 58 (4): 781–792. doi:10.1111/isqu.12176. Archived (PDF) from the original on 28 September 2018. Retrieved 24 July 2017.
Morin, Jean-Frederic (2006). "Tripping up TRIPs Debate: IP and Health" (PDF). International Journal of Intellectual Property Management. 1 (1/2): 37–53. doi:10.1504/IJIPM.2006.011021. Archived from the original (PDF) on 1 December 2017.
Morin, Jean-Frederic (2011). "The Life-Cycle of Transnational Issues: Lessons from the Access to Medicines Controversy" (PDF). Global Society. 25 (2): 227–247. doi:10.1080/13600826.2011.553914. S2CID 216592972. Archived from the original (PDF) on 6 December 2018 – via Chaire de recherche du Canada en économie politique internationale.

upenn.edu

scholarship.law.upenn.edu

Collins-Chase, Charles (Spring 2008). "The Case against TRIPS-Plus Protection in Developing Countries Facing AIDs Epidemics". University of Pennsylvania Journal of International Law. 29 (3). Archived from the original on 7 June 2015. Retrieved 23 June 2015.

web.archive.org

"TRIPS Agreement (as amended on 23 January 2017)". World Trade Organization. Archived from the original on 18 October 2020. Retrieved 12 February 2021.
"WTO – intellectual property – overview of TRIPS Agreement". World Trade Organization. Archived from the original on 25 February 2019. Retrieved 8 March 2019.
"WTO TRIPS implementation". International Intellectual Property Alliance. Archived from the original on 1 June 2012. Retrieved 22 May 2012.
Archibugi, D.; Filippetti, A. (2010). "The globalization of intellectual property rights: Four learned lessons and four thesis" (PDF). Journal of Global Policy. 1 (2): 137–149. doi:10.1111/j.1758-5899.2010.00019.x. Archived from the original (PDF) on 25 July 2011.
"intellectual property (TRIPS) – agreement text – standards". WTO. 15 April 1994. Archived from the original on 12 November 2020. Retrieved 29 October 2020.
World Trade Organization, "Part II — Standards concerning the availability, scope and use of Intellectual Property Rights; Sections 5 and 6", Agreement on Trade-Related Aspects of Intellectual Property Rights, archived from the original on 22 June 2017, retrieved 21 December 2005
World Trade Organization, "Part I — General Provisions and Basic Principles", Agreement on Trade-Related Aspects of Intellectual Property Rights, archived from the original on 12 November 2020, retrieved 28 February 2006
"WTO – intellectual property (TRIPS) – frequently-asked questions". World Trade Organization. Archived from the original on 28 May 2019. Retrieved 8 March 2019.
J.-F. Morin; R. Gold (2014). "An Integrated Model of Legal Transplantation: The Diffusion of Intellectual Property Law in Developing Countries" (PDF). International Studies Quarterly. 58 (4): 781–792. doi:10.1111/isqu.12176. Archived (PDF) from the original on 28 September 2018. Retrieved 24 July 2017.
Musungu, Sisule F.; Oh, Cecilia (August 2005), The use of flexibilities in TRIPS by developing countries: can they promote access to medicines?, Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH), archived from the original on 31 October 2013, retrieved 5 October 2020
Finger, J. Michael (2000). "The WTO's special burden on less developed countries" (PDF). Cato Journal. 19 (3). Archived from the original (PDF) on 28 July 2006.
Jean-Frederic Morin and Dimitri Theriault, How Trade Deals Extend the Frontiers of International Patent Law Archived 6 December 2018 at the Wayback Machine, CIGI Paper 199, 2018; Overview of "TRIPS-Plus" Standards – Oxford Scholarship. Oxford University Press. 2011. doi:10.1093/acprof:oso/9780195390124.003.0009. ISBN 978-0-19-989453-6. Archived from the original on 4 July 2014. Retrieved 7 October 2013.
World Trade Organization (2005). "Annual Report 2005" (PDF). Archived (PDF) from the original on 24 July 2005. Retrieved 20 July 2005.
"Index of disputes issues". World Trade Organisation. Archived from the original on 13 February 2015. Retrieved 14 August 2021.
"2005 News items – Panel reports out on geographical indications disputes". WTO. 15 March 2005. Archived from the original on 10 June 2005. Retrieved 16 April 2012.
"Canada – Term of Patent Protection : Report of the Panel" (PDF). World Trade Organization. 5 May 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"Attachment 1.1 : First Submission of the United States" (PDF). World Trade Organization. 18 November 1999. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"Canada – Term of Patent Protection - Report of the Appellate Body" (PDF). World Trade Organization. 18 September 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"United States – Section 110(5) of the US Copyright Act - Report of the Panel" (PDF). World Trade Organization. 15 June 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"Annex I - United States – Section 110(5) of US Copyright Act : Request for the Establishment of a Panel by the European Communities and their Member States" (PDF). World Trade Organization. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"Canada – Patent Protection of Pharmaceutical Products - Complaint by the European Communities and their member States - Report of the panel" (PDF). WorldTradeLaw.net. World Trade Organization. 17 March 2000. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.
"United States – Section 211 Omnibus Appropriations Act of 1998 - Report of the Panel" (PDF). World Trade Organization. 6 August 2001. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"United States – Section 211 Omnibus Appropriations Act of 1998 - Report of the Appellate Body" (PDF). World Trade Organization. 2 January 2002. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"India - Patent Protection for Pharmaceutical and Agricultural Chemical Products - Complaint by the European Communities and their member States - Report of the Panel" (PDF). WorldTradeLaw.net. World Trade Organization. 24 August 1998. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.
"WorldTradeLaw.net" (PDF). Worldtradelaw.net. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.
Collins-Chase, Charles (Spring 2008). "The Case against TRIPS-Plus Protection in Developing Countries Facing AIDs Epidemics". University of Pennsylvania Journal of International Law. 29 (3). Archived from the original on 7 June 2015. Retrieved 23 June 2015.
Morin, Jean-Frederic (2006). "Tripping up TRIPs Debate: IP and Health" (PDF). International Journal of Intellectual Property Management. 1 (1/2): 37–53. doi:10.1504/IJIPM.2006.011021. Archived from the original (PDF) on 1 December 2017.
Timmermann, Cristian; Henk van den Belt (2013). "Intellectual property and global health: from corporate social responsibility to the access to knowledge movement". Liverpool Law Review. 34 (1): 47–73. doi:10.1007/s10991-013-9129-9. S2CID 145492036. Archived from the original on 23 June 2020. Retrieved 31 October 2020.
Tosato, Andrea; Igbokwe, Ezinne (January 2023). "Access to Medicines and Pharmaceutical Patents: Fulfilling the Promise of TRIPS Article 31bis". Fordham Law Review. 91 (5): 1791. Archived from the original on 17 December 2023. Retrieved 23 July 2023.
Morin, Jean-Frederic (2011). "The Life-Cycle of Transnational Issues: Lessons from the Access to Medicines Controversy" (PDF). Global Society. 25 (2): 227–247. doi:10.1080/13600826.2011.553914. S2CID 216592972. Archived from the original (PDF) on 6 December 2018 – via Chaire de recherche du Canada en économie politique internationale.
Nebehay, Stephanie; Farge, Emma (10 December 2020). "WTO delays decision on waiver on COVID-19 drug, vaccine rights". Reuters. Archived from the original on 28 February 2021. Retrieved 25 February 2021.
"Members to continue discussion on proposal for temporary IP waiver in response to COVID-19". World Trade Organisation. Archived from the original on 27 February 2021. Retrieved 25 February 2021.
Baker, Brook K.; Labonte, Ronald (9 January 2021). "Dummy's guide to how trade rules affect access to COVID-19 vaccines". The Conversation. Archived from the original on 23 February 2021. Retrieved 25 February 2021.
"An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines". Cato Institute. 16 December 2020. Archived from the original on 25 February 2021. Retrieved 25 February 2021.

who.int

Musungu, Sisule F.; Oh, Cecilia (August 2005), The use of flexibilities in TRIPS by developing countries: can they promote access to medicines?, Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH), archived from the original on 31 October 2013, retrieved 5 October 2020

wiley.com

onlinelibrary.wiley.com

Banerjee, Tannista; Nayak, Arnab (14 March 2014). "Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry". Journal of Pharmaceutical Health Services Research. 5 (2): 89–94. doi:10.1111/jphs.12050. S2CID 70896207.

worldtradelaw.net

"Canada – Patent Protection of Pharmaceutical Products - Complaint by the European Communities and their member States - Report of the panel" (PDF). WorldTradeLaw.net. World Trade Organization. 17 March 2000. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.
"India - Patent Protection for Pharmaceutical and Agricultural Chemical Products - Complaint by the European Communities and their member States - Report of the Panel" (PDF). WorldTradeLaw.net. World Trade Organization. 24 August 1998. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.
"WorldTradeLaw.net" (PDF). Worldtradelaw.net. Archived (PDF) from the original on 14 May 2019. Retrieved 8 March 2019.

wto.int

"Index of disputes issues". World Trade Organisation. Archived from the original on 13 February 2015. Retrieved 14 August 2021.

wto.org

"TRIPS Agreement (as amended on 23 January 2017)". World Trade Organization. Archived from the original on 18 October 2020. Retrieved 12 February 2021.
"WTO – intellectual property – overview of TRIPS Agreement". World Trade Organization. Archived from the original on 25 February 2019. Retrieved 8 March 2019.
"intellectual property (TRIPS) – agreement text – standards". WTO. 15 April 1994. Archived from the original on 12 November 2020. Retrieved 29 October 2020.
World Trade Organization, "Part II — Standards concerning the availability, scope and use of Intellectual Property Rights; Sections 5 and 6", Agreement on Trade-Related Aspects of Intellectual Property Rights, archived from the original on 22 June 2017, retrieved 21 December 2005
World Trade Organization, "Part I — General Provisions and Basic Principles", Agreement on Trade-Related Aspects of Intellectual Property Rights, archived from the original on 12 November 2020, retrieved 28 February 2006
"WTO – intellectual property (TRIPS) – frequently-asked questions". World Trade Organization. Archived from the original on 28 May 2019. Retrieved 8 March 2019.
World Trade Organization (2005). "Annual Report 2005" (PDF). Archived (PDF) from the original on 24 July 2005. Retrieved 20 July 2005.
"2005 News items – Panel reports out on geographical indications disputes". WTO. 15 March 2005. Archived from the original on 10 June 2005. Retrieved 16 April 2012.
"Canada – Term of Patent Protection : Report of the Panel" (PDF). World Trade Organization. 5 May 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"Attachment 1.1 : First Submission of the United States" (PDF). World Trade Organization. 18 November 1999. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"Canada – Term of Patent Protection - Report of the Appellate Body" (PDF). World Trade Organization. 18 September 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"United States – Section 110(5) of the US Copyright Act - Report of the Panel" (PDF). World Trade Organization. 15 June 2000. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"Annex I - United States – Section 110(5) of US Copyright Act : Request for the Establishment of a Panel by the European Communities and their Member States" (PDF). World Trade Organization. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"United States – Section 211 Omnibus Appropriations Act of 1998 - Report of the Panel" (PDF). World Trade Organization. 6 August 2001. Archived (PDF) from the original on 10 September 2019. Retrieved 8 March 2019.
"United States – Section 211 Omnibus Appropriations Act of 1998 - Report of the Appellate Body" (PDF). World Trade Organization. 2 January 2002. Archived (PDF) from the original on 9 September 2019. Retrieved 8 March 2019.
"Members to continue discussion on proposal for temporary IP waiver in response to COVID-19". World Trade Organisation. Archived from the original on 27 February 2021. Retrieved 25 February 2021.

wur.nl

library.wur.nl

Timmermann, Cristian; Henk van den Belt (2013). "Intellectual property and global health: from corporate social responsibility to the access to knowledge movement". Liverpool Law Review. 34 (1): 47–73. doi:10.1007/s10991-013-9129-9. S2CID 145492036. Archived from the original on 23 June 2020. Retrieved 31 October 2020.